What Myeloma Updates You Need To Know with Dr. Manni Mohyuddin
Join Huntsman’s newest multiple myeloma specialist, Dr. Manni Mohyuddin, as he summarizes some of the most exciting and thought-provoking multiple myeloma research this year. Dr. Mohyuddin will explain his highlights from the 2021 International Myeloma Workshop (IMW) research conference, focusing on those findings most likely to influence today’s medical decisions about real-world patient care. As always, our meeting will feature an interactive question and answer session too.
Audrey Burton-Bethke
Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Nico Cheek-O'Donnell
Nico joined the Multiple Myeloma Program at Huntsman Cancer Institute in 2016, as its licensed clinical social worker. Before that, he was a social worker with Intermountain, primarily at LDS Hospital on their inpatient behavioral unit. He earned his Master of Social Work degree at the University of Utah. Originally from New York & Boston, Nico earned undergraduate degrees in Psychology & Theatre from Carleton College in Minnesota. He earned most of his very modest living as a stage actor in Minneapolis and Seattle for eight years, before moving to Utah in 2006. More recently, Nico has used role-play to help train physicians how to navigate especially difficult patient conversations – and to entertain his 13 & 9-year-old kids.
Ghulam (Manni) Mohyuddin, MD
Dr. Mohyuddin completed his medical training at the prestigious Aga Khan University in Pakistan. He completed his internal medicine residency at the University of Kansas where he developed a passion for medical education and treating hematological malignancies. After residency, he pursued Chief Residency at the University of Kansas, focusing on mechanisms of novel educational delivery and improving access to research for trainees. He completed his fellowship at the University of Kansas, developing a clinical and research interest in multiple myeloma, drug repurposing, quality of scientific methods, end of life, cost-effective/evidence-based care and medical education. He enjoys the outdoors tremendously, and that drew him to life in Utah where he is currently an Assistant Professor at the Huntsman Cancer Institute with a focus on multiple myeloma.